Revance Therapeutics, Inc. (RVNC)

NASDAQ: RVNC · IEX Real-Time Price · USD

3.780

-0.010 (-0.26%)

At close: Apr 19, 2024, 4:00 PM

3.730

-0.050 (-1.32%)

After-hours: Apr 19, 2024, 7:30 PM EDT

Revance Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2011
Market Capitalization	394	772	1,519	1,172	1,886	732	745	1,106	590	959	402	Upgrade
Market Cap Growth	-	-49.18%	29.62%	-37.87%	157.61%	-1.67%	-32.67%	87.36%	-38.42%	138.57%	-	Upgrade
Enterprise Value	614	996	1,597	1,266	1,658	471	568	824	410	715	234	Upgrade
PE Ratio	-2.38	-2.38	-4.26	-4.16	-6.69	-4.59	-5.22	-9.17	-6.61	-13.05	-6.39	Upgrade
PS Ratio	1.67	3.30	11.46	15.06	123.07	1772.66	199.67	4221.05	1967.54	3195.35	1049.13	Upgrade
PB Ratio	-5.09	-5.09	120.54	17.11	5.04	3.25	5.11	4.11	3.33	3.79	2.28	Upgrade
P/FCF Ratio	-3.45	-3.45	-7.72	-5.05	-10.33	-6.69	-6.78	-11.30	-9.60	-16.25	-6.48	Upgrade
P/OCF Ratio	-3.56	-3.56	-7.85	-5.29	-10.57	-6.90	-7.14	-11.60	-9.87	-17.22	-7.30	Upgrade
EV/Sales Ratio	2.62	4.26	12.04	16.27	108.20	1139.48	152.32	3146.23	1365.00	2382.50	611.61	Upgrade
EV/EBITDA Ratio	-3.43	-3.43	-5.32	-4.96	-6.39	-3.01	-4.12	-6.95	-4.72	-10.17	-4.67	Upgrade
EV/EBIT Ratio	-3.27	-3.27	-4.71	-4.60	-6.15	-2.95	-4.07	-6.86	-4.64	-9.89	-4.48	Upgrade
EV/FCF Ratio	-4.46	-4.46	-8.11	-5.46	-9.08	-4.30	-5.17	-8.42	-6.66	-12.12	-3.78	Upgrade
Debt / Equity Ratio	-3.16	-3.16	33.21	4.74	0.57	0.13	-	0.01	0.03	0.03	0.02	Upgrade
Debt / EBITDA Ratio	-1.65	-1.65	-1.39	-1.27	-0.82	-0.19	-	-0.02	-0.06	-0.12	-0.07	Upgrade
Debt / FCF Ratio	-2.14	-2.14	-2.13	-1.40	-1.16	-0.27	-	-0.02	-0.09	-0.14	-0.06	Upgrade
Quick Ratio	3.16	3.16	4.65	3.47	7.25	7.10	6.37	13.56	9.47	20.96	16.72	Upgrade
Current Ratio	3.80	3.80	4.95	3.66	7.38	7.24	6.50	13.65	9.81	21.10	16.88	Upgrade
Asset Turnover	0.43	0.43	0.21	0.13	0.02	0.00	0.02	0.00	0.00	0.00	0.00	Upgrade
Interest Coverage	-15.72	-15.72	-20.59	-43.84	-17.80	-	-3171.00	-262.87	-81.50	-60.74	-4.90	Upgrade
Return on Equity (ROE)	502.90%	502.90%	-786.70%	-181.70%	-86.10%	-81.10%	-73.70%	-64.40%	-43.00%	-41.50%	-39.20%	Upgrade
Return on Assets (ROA)	-60.10%	-60.10%	-57.10%	-46.30%	-43.40%	-52.00%	-56.80%	-56.00%	-38.50%	-37.30%	-34.40%	Upgrade
Return on Capital (ROIC)	-96.92%	-96.92%	-79.33%	-69.90%	-46.58%	-64.54%	-97.95%	-44.48%	-48.36%	-27.63%	-28.93%	Upgrade
Earnings Yield	-83.12%	-41.97%	-23.47%	-24.01%	-14.96%	-21.78%	-19.15%	-10.90%	-15.12%	-7.66%	-15.66%	Upgrade
FCF Yield	-57.33%	-28.95%	-12.96%	-19.79%	-9.68%	-14.94%	-14.75%	-8.85%	-10.42%	-6.15%	-15.44%	Upgrade
Buyback Yield / Dilution	-16.35%	-16.35%	-7.71%	-16.37%	-33.47%	-20.15%	-20.17%	-7.07%	-15.51%	-25.52%	-1784.23%	Upgrade
Total Shareholder Return	-16.35%	-16.35%	-7.71%	-16.37%	-33.47%	-20.15%	-20.17%	-7.07%	-15.51%	-25.52%	-1784.23%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).